Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or metastatic soft tissue sarcoma: An European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group randomised phase II and pharmacogenetic study

H. Gelderblom, J. Y. Blay, B. M. Seddon, M. Leahy, I. Ray-Coquard, S. Sleijfer, J. M. Kerst, P. Rutkowski, S. Bauer, M. Ouali, S. Marreaud, R. J.H.M. Van Der Straaten, H. J. Guchelaar, S. D. Weitman, P. C.W. Hogendoorn, P. Hohenberger

Research output: Contribution to journalArticlepeer-review

23 Scopus citations

Fingerprint Dive into the research topics of 'Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or metastatic soft tissue sarcoma: An European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group randomised phase II and pharmacogenetic study'. Together they form a unique fingerprint.

Medicine & Life Sciences